Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
ABCB1 encodes Multidrug Resistance Protein which promotes efflux of chemotherapeutic and targeted agents. Here, in breast and ovarian cancer the authors identify multiple transcriptional fusion partners involving ABCB1 that are associated with treatment failure and previous treatment regimens.
Enregistré dans:
Auteurs principaux: | Elizabeth L. Christie, Swetansu Pattnaik, Jessica Beach, Anthony Copeland, Nineveh Rashoo, Sian Fereday, Joy Hendley, Kathryn Alsop, Samuel L. Brady, Greg Lamb, Ahwan Pandey, Anna deFazio, Heather Thorne, Andrea Bild, David D. L. Bowtell |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d60dcd89a874c7d9dd75f1ea6c6ed3b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
par: Kathleen I. Pishas, et autres
Publié: (2021) -
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
par: Aritro Nath, et autres
Publié: (2021) -
A transportome-scale amiRNA-based screen identifies redundant roles of Arabidopsis ABCB6 and ABCB20 in auxin transport
par: Yuqin Zhang, et autres
Publié: (2018) -
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
par: Mugosa Snezana, et autres
Publié: (2021) -
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
par: Durgagauri H. Sabnis, et autres
Publié: (2019)